Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Prolymphocytic, T-Cell × ibrutinib × 1 year × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 47 Lymphoma, Mantle-Cell 26 Lymphoma, Non-Hodgkin 15 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma, Follicular 12 Lymphoma 11 Waldenstrom Macroglobulinemia 10 Lymphoma, B-Cell, Marginal Zone 8 Recurrence 6 Leukemia 6 Neoplasms 5 Lymphoma, B-Cell 5 Bronchiolitis Obliterans Syndrome 5 Multiple Myeloma 3 Leukemia, Prolymphocytic 3 Leukemia, B-Cell 3 Hematologic Neoplasms 3 Hematologic Diseases 3 Graft vs Host Disease 3 Burkitt Lymphoma 3 Melanoma 2 Leukemia, Lymphoid 2 Leukemia, Hairy Cell 2 Glioblastoma 2 Brain Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 1 Primary Central Nervous System Lymphoma (PCNSL) 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurologic Manifestations 1 Neuroectodermal Tumors, Primitive 1

Interventions

ruxolitinib 3 venetoclax 2 duvelisib 2 thymoglobulin 1 romidepsin 1 itacitinib 1 fludarabine phosphate 1 fludarabine 1 Stem Cell Transplantation 1 Lisaftoclax 1 Depsipeptides 1 Cladribine 1 Busulfan 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡